{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:59:02Z","timestamp":1785459542005,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05024-y","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:34:28Z","timestamp":1781915668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation"],"prefix":"10.1186","volume":"26","author":[{"given":"Alina","family":"Flintere-Flinte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimirs","family":"Krutovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabete","family":"Pantelejeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksims","family":"Zolovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktorija","family":"Kenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"5024_CR1","doi-asserted-by":"publisher","unstructured":"Fabian MT, Krieger SC, Lublin FD. Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System. In: Bradley and Daroff's Neurology in Clinical Practice: Volume 1-2. 8th ed. Elsevier; 2021. Vol. 2. pp. 1226-54.e5). https:\/\/doi.org\/10.1016\/B978-0-323-64261-3.00080-2.","DOI":"10.1016\/B978-0-323-64261-3.00080-2"},{"issue":"10","key":"5024_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/aje\/kwk118","volume":"165","author":"H Schmidt","year":"2007","unstructured":"Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol. 2007;165(10):1097\u2013109. https:\/\/doi.org\/10.1093\/aje\/kwk118.","journal-title":"Am J Epidemiol"},{"issue":"10130","key":"5024_CR3","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1.","journal-title":"Lancet"},{"issue":"8","key":"5024_CR4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.clinph.2008.04.010","volume":"119","author":"S Misawa","year":"2008","unstructured":"Misawa S, Kuwabara S, Mori M, Hayakawa S, Sawai S, Hattori T. Peripheral nerve demyelination in multiple sclerosis. Clin Neurophysiol. 2008;119(8):1829\u201333. https:\/\/doi.org\/10.1016\/j.clinph.2008.04.010.","journal-title":"Clin Neurophysiol"},{"issue":"8","key":"5024_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/cns.12127","volume":"19","author":"S Yokobori","year":"2013","unstructured":"Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R. Biomarkers for the clinical differential diagnosis in traumatic brain injury\u2013a systematic review. CNS Neurosci Ther. 2013;19(8):556\u201365. https:\/\/doi.org\/10.1111\/cns.12127.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"5024_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00686997","volume":"65","author":"A Paetau","year":"1985","unstructured":"Paetau A, Elovaara I, Paasivuo R, Virtanen I, Palo J, Haltia M. Glial filaments are a major brain fraction in infantile neuronal ceroid-lipofuscinosis. Acta Neuropathol. 1985;65(3):190\u20134. https:\/\/doi.org\/10.1007\/BF00686997.","journal-title":"Acta Neuropathol"},{"key":"5024_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil M, Teunissen CE, Lehmann S, et al. Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application. Nat Rev Neurol. 2024;20:269\u201387. https:\/\/doi.org\/10.1038\/s41582-024-00955-x.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"5024_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1352458518819380","volume":"26","author":"H H\u00f6gel","year":"2020","unstructured":"H\u00f6gel H, Rissanen E, Barro C, Matilainen M, Nylund M, Kuhle J, Airas L. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. Mult Scler. 2020;26(2):210\u20139. https:\/\/doi.org\/10.1177\/1352458518819380.","journal-title":"Mult Scler"},{"issue":"12","key":"5024_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","volume":"80","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak A, Benkert P, Schaedelin S, et al. Neurofilament light chain elevation and disability progression in multiple sclerosis. JAMA Neurol. 2023;80(12):1317\u201325. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3997.","journal-title":"JAMA Neurol"},{"issue":"10","key":"5024_CR10","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):e1007\u201315. https:\/\/doi.org\/10.1212\/WNL.0000000000007032.","journal-title":"Neurology"},{"key":"5024_CR11","doi-asserted-by":"publisher","first-page":"102810","DOI":"10.1016\/j.msard.2021.102810","volume":"50","author":"M Saraste","year":"2021","unstructured":"Saraste M, Bezukladova S, Matilainen M, Sucksdorff M, Kuhle J, Leppert D, Airas L. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI. Multiple Scler Relat Disorders. 2021;50:102810. https:\/\/doi.org\/10.1016\/j.msard.2021.102810.","journal-title":"Multiple Scler Relat Disorders"},{"key":"5024_CR12","doi-asserted-by":"crossref","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","DOI":"10.1212\/WNL.33.11.1444"},{"issue":"3","key":"5024_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5024_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.54029\/2024zij","volume":"29","author":"HQ Jabbar","year":"2024","unstructured":"Jabbar HQ, Hassoun HK, Allebban Z. Serum neurofilament level as biomarker in multiple sclerosis. Neurol Asia. 2024;29(1):183\u201391. https:\/\/doi.org\/10.54029\/2024zij.","journal-title":"Neurol Asia"},{"issue":"22","key":"5024_CR15","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","volume":"89","author":"L Novakova","year":"2017","unstructured":"Novakova L, Zetterberg H, Sundstr\u00f6m P, Axelsson M, Khademi M, Gunnarsson M, Malmestr\u00f6m C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Am Acad Neurol. 2017;89(22):2230\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000004683.","journal-title":"Am Acad Neurol"},{"issue":"5","key":"5024_CR16","doi-asserted-by":"publisher","first-page":"e02084","DOI":"10.1002\/brb3.2084","volume":"11","author":"T Hayashi","year":"2021","unstructured":"Hayashi T, Nukui T, Piao JL, et al. Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy. Brain Behav. 2021;11(5):e02084. https:\/\/doi.org\/10.1002\/brb3.2084.","journal-title":"Brain Behav"},{"key":"5024_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neubiorev.2019.04.014","volume":"102","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Xin Y, Meng S, He Z, Hu W. Neurofilament light chain protein in neurodegenerative dementia: a systematic review and network meta-analysis. Neurosci Biobehavioral Reviews. 2019;102:123\u201338. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.014.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"5024_CR18","volume-title":"CSF neurofilament light chain testing as an aid to determine treatment strategies in MS","author":"S Reyes","year":"2020","unstructured":"Reyes S, Smets I, Holden D, Carrillo-Loza K, Christmas T, Bianchi L, Ammoscato F, Turner B, Marta M, Schmierer K, Giovannoni G, Gnanapavan S. CSF neurofilament light chain testing as an aid to determine treatment strategies in MS. Volume 7. Neurology\u00ae: Neuroimmunology & Neuroinflammation; 2020. 6e880."},{"key":"5024_CR19","doi-asserted-by":"publisher","unstructured":"Einsiedler M. Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores\/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response. Ann Clin Transl Neurol. 2025;12(11):2214-2225. https:\/\/doi.org\/10.1002\/acn3.70149. Epub 2025 Aug 3. PMID: 40755082; PMCID: PMC12623839.","DOI":"10.1002\/acn3.70149"},{"issue":"1","key":"5024_CR20","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.1038\/s41598-020-67934-2","volume":"10","author":"X Ayrignac","year":"2020","unstructured":"Ayrignac X, Le Bars E, Duflos C, Hirtz C, Maleska Maceski A, Carra-Dalli\u00e8re C, Charif M, Pinna F, Prin P, Menjot de Champfleur N, Deverdun J, Kober T, Marechal B, Fartaria MJ, Corredor Jerez R, Labauge P, Lehmann S. Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity. Sci Rep. 2020;10(1):10923. https:\/\/doi.org\/10.1038\/s41598-020-67934-2.","journal-title":"Sci Rep"},{"issue":"1","key":"5024_CR21","doi-asserted-by":"publisher","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","volume":"8","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M. Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep. 2018;8(1):14798. https:\/\/doi.org\/10.1038\/s41598-018-33158-8.","journal-title":"Sci Rep"},{"issue":"1","key":"5024_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","volume":"16","author":"T Ziemssen","year":"2019","unstructured":"Ziemssen T, Akg\u00fcn K, Br\u00fcck W. Molecular biomarkers in multiple sclerosis. J Neuroinflamm. 2019;16(1):272. https:\/\/doi.org\/10.1186\/s12974-019-1674-2.","journal-title":"J Neuroinflamm"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05024-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:08:58Z","timestamp":1785456538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5024"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05024-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study was approved by R\u012bga Stradi\u0146\u0161 University Research Ethics Committee (Institutional Review Board reference no: 2-P\u0112K-4\/508\/2022).This study was approved by the R\u012bga Stradi\u0146\u0161 University Research Ethics Committee (Institutional Review Board reference no: 2-P\u0112K-4\/508\/2022). All methods were carried out in accordance with relevant guidelines and regulations and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all participants prior to participation.Written informed consent was obtained from all individuals before participation in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No identifiable images or personal data are included in the manuscript, this is Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"485"}}